ABCB1 reduces intracellular concentrations of cytotoxic drugs, and is associated with chemotherapy resistance in bladder cancer [36] and with chemotherapy resistance and shorter survival in lung cancer [46]. Here, ABCB1 is linked to urinary bladder cancer.